This inventor holds 4 USPTO granted patents. Top assignee: Ames-Yissum Ltd.. Active years: 1979-1981.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1979-1981
Title: Innovating Assay Methods: The Contributions of Daniel B. Wagner
Introduction: Daniel B. Wagner, an accomplished inventor based in Jerusalem, Israel, has made significant strides in the field of assay methods with a total of four patents to his name. His inventions primarily focus on techniques for determining ligands in liquid mediums, particularly in the context of body fluids such as serum.
Latest Patents: Wagner's latest patents include groundbreaking methods such as the "Multilayer Column Chromatography Specific Binding Assay Method" and a test device tailored for identifying ligands like antigens or antibodies. These innovative methods utilize a principle where an unknown ligand competes with a labeled component for binding with a binding partner. A distinctive feature of his approach is the integration of additional capillary absorbent materials within the columns, which enhances separation efficiency between bound and free species. This novel technique addresses challenges encountered in previous methodologies, making it a significant advancement in assay applications, particularly in radioimmunoassays.
Career Highlights: Daniel B. Wagner's career is marked by not only his inventive contributions but also his association with Ames Yissum Ltd., a prominent entity in the field of research and development. His work emphasizes practicality and adaptability, paving the way for automated processes that enhance laboratory efficiency.
Collaborations: Wagner's endeavors have been further enriched through collaboration with esteemed colleagues such as Judith Feingers and Anthony J. Pick. Their combined expertise has contributed to the innovation and implementation of cutting-edge technologies in the field of biochemical assays.
Conclusion: Daniel B. Wagner stands out as a pivotal figure in the advancement of assay methods, with his patents reflecting a commitment to improving the precision and efficiency of ligand detection. His ongoing work promises to impact various applications in medical and biochemical research, underscoring the importance of innovation in science and technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile